Reports for PALADIN PHARMA INC.

Company Name

PALADIN PHARMA INC.

Totals

Shortage reports

122
Actual shortage: 23 (19%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 94 (77%)

Discontinuation Reports

34
To be discontinued: 3 (9%)
Discontinued: 31 (91%)
Reversed: 0 (0%)

Late reports

40 (26%)

Overdue reports

8 (31%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ANACIN 32MG 325MG TABLET Actual shortage 2023-07-13 2023-07-13 198613
ABSTRAL 200MCG TABLET Resolved 2017-05-16 2017-11-30 10415

Showing 121 to 122 of 122

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MOVAPO 10MG SOLUTION To be discontinued 2023-10-20 2023-11-17 207624
CORTIFOAM Discontinued 2020-03-12 2020-03-13 108638
CANTHACUR-PS 30% 1% 5% LIQUID Discontinued 2018-01-26 2018-01-27 37443
BETNESOL RETENTION ENEMA 5MG/100ML 5MG ENEMA To be discontinued 2021-11-25 2021-11-25 149892
BELLERGAL SPACETABS 0.2MG 40.0MG 0.6MG TABLET (EXTENDED-RELEASE) Discontinued 2018-06-06 2018-06-07 51736
AURALGAN 54MG 14MG SOLUTION Discontinued 2022-07-25 2022-07-26 165407
ANACIN EXTRA STRENGTH 500MG 32MG TABLET Discontinued 2019-06-04 2019-06-04 85519
ANACIN 32MG 325MG TABLET To be discontinued 2023-04-13 2023-08-02 189549
ABSTRAL 100MCG TABLET Discontinued 2018-07-26 2018-07-26 56578
ABSTRAL 200MCG TABLET Discontinued 2018-07-26 2018-07-26 56638
ABSTRAL 300MCG TABLET Discontinued 2018-07-26 2018-07-26 56643
ABSTRAL 400MCG TABLET Discontinued 2018-07-26 2018-07-26 56646
ABSTRAL 600MCG TABLET Discontinued 2018-07-26 2018-07-26 56649
ABSTRAL 800MCG TABLET Discontinued 2018-07-26 2018-07-26 56652

Showing 21 to 34 of 34